Felodipine
NDC 62135-646, Felodipine, tablet, extended release, from Chartwell RX, LLC.
- Product NDC
- 62135-646
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210847
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-646 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FELODIPINE2.5 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-646-90 | 62135064690 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62135-646-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/fddebfce-70ed-4ee1-8598-bbb8f1ca9263NADAC price for package 62135064690
GET /v1/drugs/nadac/62135064690
Use it
Look up 62135-646 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-646 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-646. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.